Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice.
Increasing numbers of female patients survive cancer, but succumb to primary ovarian insufficiency after chemotherapy. We tested the hypothesis that Bortezomib (Bort) protects ovaries from doxorubicin (DXR) chemotherapy by treating female mice with Bort 1 hour prior to DXR. By preventing DXR accumul...
Saved in:
| Main Authors: | Elon C Roti Roti, Ashley K Ringelstetter, Jenna Kropp, David H Abbott, Sana M Salih |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0108174 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The birth and demise of a village within the vernacular community of Baduy in Banten, Indonesia
by: Irfan Sabarilah Hasim, et al.
Published: (2025-02-01) -
The rise & demise of the Afrikaners
by: Wessel Visser
Published: (2022-07-01) -
Bortezomib
by: Rajappa Senthil
Published: (2010-12-01) -
Periodization of the brain ischemic insult
by: K. V. Serikov, et al.
Published: (2019-12-01) -
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES
by: Giovanni Roti, et al.
Published: (2019-06-01)